Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Hypertension prevalence, awareness, treatment, and control in northeast China: a population-based cross-sectional survey

Journal of Human Hypertension volume 32, pages 54–65 (2018)Cite this article

Subjects

Abstract

Hypertension has been recognized as a major risk factor for cardiovascular disease. We aimed to analyze the current prevalence, awareness, treatment, and control of hypertension in northeast China. This cross-sectional survey adopted the multistage stratified random cluster sampling method to obtain a representative sample of adults aged 40 years or older in the general population of northeast China. Hypertension was defined as a systolic blood pressure (SBP) ≥ 140 mm Hg, or diastolic blood pressure (DBP) ≥ 90 mm Hg, or self-reported use of antihypertensive medications in the last 2 weeks irrespective of BP. Altogether 4052 participants were included with weighted prevalence of hypertension of 57.3%. Among them, 47.4% were aware of their condition; 78.8% took antihypertensive medication, but only 10.2% had their blood pressure controlled. Individuals who were overweight/obesity, with dyslipidemia, or diabetes were at a higher risk of hypertension; these people also more likely to be aware of their condition. Subjects with a personal history of stroke were more inclined to receive antihypertensive medication, but that did not necessarily translate to well-controlled hypertension. Moreover, dyslipidemia (OR = 0.600; 95% CI: 0.375, 0.960) were associated with poor hypertension control. Subjects using combination of antihypertensive medications (OR = 2.924; 95% CI: 1.606, 5.325) or with a family history of coronary heart disease were more likely to have their blood pressure controlled. Our study identified a high prevalence of hypertension in northeast China. Although awareness and treatment rates improved over the last decade, the control rate remained disproportionately and unacceptably low.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Lackland DT, Weber MA. Global burden of cardiovascular disease and stroke: hypertension at the core. Can J Cardiol. 2015;31:569–71.

    Article  Google Scholar 

  2. Lawes CM, Vander Hoorn S, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet (London, England). 2008;371:1513–8.

    Article  Google Scholar 

  3. GBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1659–724.

    Article  Google Scholar 

  4. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217–23.

    Article  Google Scholar 

  5. Yang G, Wang Y, Zeng Y, Gao GF, Liang X, Zhou M, et al. Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet. 2013;381:1987–2015.

    Article  Google Scholar 

  6. Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016;134:441–50.

    Article  Google Scholar 

  7. Bundy JD, He J, Hypertension and related cardiovascular disease burden in China. Annals of global health. 2016;82:227–33

    Article  Google Scholar 

  8. Li Z, Guo X, Zheng L, Yang H, Sun Y. Grim status of hypertension in rural China: results from Northeast China Rural Cardiovascular Health Study 2013. J Am Soc Hypertens. 2015;9:358–64.

    Article  Google Scholar 

  9. Wei Q, Sun J, Huang J, Zhou HY, Ding YM, Tao YC, et al. Prevalence of hypertension and associated risk factors in Dehui City of Jilin Province in China. J Hum Hypertens. 2015;29:64–8.

    Article  CAS  Google Scholar 

  10. Sun H, Zou X, Liu L. Epidemiological factors of stroke: a survey of the current status in china. J Stroke. 2013;15:109–14.

    Article  Google Scholar 

  11. Zhang FL, Xing YQ, Wu YH, Liu HY, Luo Y, Sun MS, et al. The prevalence, awareness, treatment, and control of dyslipidemia in northeast China: a population-based cross-sectional survey. Lipids Health Dis. 2017;16:61.

    Article  CAS  Google Scholar 

  12. Wu Y, Huxley R, Li L, Anna V, Xie G, Yao C, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002. Circulation. 2008;118:2679–86.

    Article  Google Scholar 

  13. Lewington S, Lacey B, Clarke R, Guo Y, Kong XL, Yang L, et al. The burden of hypertension and associated risk for cardiovascular mortality in China. JAMA Internal Med. 2016;176:524–32.

    Article  Google Scholar 

  14. Wang J, Zhang L, Wang F, Liu L, Wang H. Prevalence, awareness, treatment, and control of hypertension in China: results from a national survey. Am J Hypertens. 2014;27:1355–61.

    Article  CAS  Google Scholar 

  15. Yin M, Augustin B, Fu Z, Yan M, Fu A, Yin P. Geographic distributions in hypertension diagnosis, measurement, prevalence, awareness, treatment and control rates among middle-aged and older adults in China. Sci Rep. 2016;6:37020.

    Article  CAS  Google Scholar 

  16. Li Y, Yang L, Wang L, Zhang M, Huang Z, Deng Q, et al. Burden of hypertension in China: a nationally representative survey of 174,621 adults. Int J Cardiol. 2017;227:516–23.

    Article  Google Scholar 

  17. Li G, Wang H, Wang K, Wang W, Dong F, Qian Y, et al. Prevalence, awareness, treatment, control and risk factors related to hypertension among urban adults in Inner Mongolia 2014: differences between Mongolian and Han populations. BMC Public Health. 2016;16:294.

    Article  Google Scholar 

  18. Yang L, Yan J, Tang X, Xu X, Yu W, Wu H. Prevalence, awareness, treatment, control and risk factors associated with hypertension among adults in southern China, 2013. PloS ONE. 2016;11:e0146181.

    Article  Google Scholar 

  19. Fan L, Feng SX, Han B, Wang CC, Gao L, Feng HF, et al. Prevalence, awareness, treatment and control of hypertension in Henan Province, China. Aust J Rural Health. 2014;22:264–9.

    Article  Google Scholar 

  20. Hu Y, Wang Z, Wang Y, Wang L, Han W, Tang Y, et al. Prevalence, awareness, treatment, and control of hypertension among Kazakhs with high salt intake in Xinjiang, China: A Community-based Cross-sectional Study. Sci Rep. 2017;7:45547.

    Article  CAS  Google Scholar 

  21. Leng B, Jin Y, Li G, Chen L, Jin N. Socioeconomic status and hypertension: a meta-analysis. J Hypertens. 2015;33:221–9.

    Article  CAS  Google Scholar 

  22. Shao S, Hua Y, Yang Y, Liu X, Fan J, Zhang A, et al. Salt reduction in China: a state-of-the-art review. Risk Manag Healthcare Policy. 2017;10:17–28.

    Article  Google Scholar 

  23. Ke L, Ho J, Feng J, Mpofu E, Dibley MJ, Li Y, et al. Prevalence, awareness, treatment and control of hypertension in Macau: results from a cross-sectional epidemiological study in Macau, China. Am J Hypertens. 2015;28:159–65.

    Article  CAS  Google Scholar 

  24. Wang H, Zhang X, Zhang J, He Q, Hu R, Wang L, et al. Factors associated with prevalence, awareness, treatment and control of hypertension among adults in Southern China: a community-based, cross-sectional survey. PloS ONE. 2013;8:e62469.

    Article  CAS  Google Scholar 

  25. Rubinstein AL, Irazola VE, Calandrelli M, Chen CS, Gutierrez L, Lanas F, et al. Prevalence, awareness, treatment, and control of hypertension in the southern cone of Latin America. Am J Hypertens. 2016;29:1343–52.

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Wang Y, Klaric L, Yu X, Thaqi K, Dong J, Novokmet M, et al. The association between glycosylation of immunoglobulin g and hypertension: A Multiple Ethnic Cross-Sectional Study. Medicine. 2016;95:e3379.

    Article  CAS  Google Scholar 

  27. Shao S, Zhao F, Wang J, Feng L, Lu X, Du J, et al. The ecology of medical care in Beijing. PloS ONE. 2013;8:e82446.

    Article  Google Scholar 

  28. Wang W, Russell A, Yan Y. Traditional Chinese medicine and new concepts of predictive, preventive and personalized medicine in diagnosis and treatment of suboptimal health. EPMA J. 2014;5:4.

    Article  Google Scholar 

  29. Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013;310:959–68.

    Article  CAS  Google Scholar 

  30. Guo F, He D, Zhang W, Walton RG. Trends in prevalence, awareness, management, and control of hypertension among United States adults, 1999 to 2010. J Am Coll Cardiol. 2012;60:599–606.

    Article  Google Scholar 

  31. McAlister FA, Wilkins K, Joffres M, Leenen FH, Fodor G, Gee M, et al. Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades. CMAJ. 2011;183:1007–13.

    Article  Google Scholar 

  32. Nolte CH, Jungehulsing GJ, Rossnagel K, Roll S, Haeusler KG, Reich A, et al. Vascular risk factor awareness before and pharmacological treatment before and after stroke and TIA. Eur J Neurol. 2009;16:678–83.

    Article  CAS  Google Scholar 

  33. Muntner P, DeSalvo KB, Wildman RP, Raggi P, He J, Whelton PK. Trends in the prevalence, awareness, treatment, and control of cardiovascular disease risk factors among noninstitutionalized patients with a history of myocardial infarction and stroke. Am J Epidemiol. 2006;163:913–20.

    Article  Google Scholar 

  34. Li W, Gu H, Teo KK, Bo J, Wang Y, Yang J, et al. Hypertension prevalence, awareness, treatment, and control in 115 rural and urban communities involving 47 000 people from China. J Hypertens. 2016;34:39–46.

    Article  CAS  Google Scholar 

  35. Huang Y, Huang W, Mai W, Cai X, An D, Liu Z, et al. White-coat hypertension is a risk factor for cardiovascular diseases and total mortality. J Hypertens. 2017;35:677–88.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We gratefully acknowledge all study participants, interviewers from the First Hospital of Jilin University, and the support from the Chinese National Center for Stroke Care Quality Control and Management. This project was supported by the National Natural Science Foundation of China to Yi Yang (Grant No. 81571123), the National Key R&D Program of China (2016YFC1301600) to Yi Yang. This project was also supported by the Young Elite Scientists Sponsorship Program by CAST to Zhen-Ni Guo.

Author contributions

Conception and design Y.-Q.X. and Y.Y. Acquisition of the data F.-L.Z. and H.-Y.L. Analysis F.-L.Z. and Y.-H.W. Drafting the manuscript F.-L.Z. Critical revision Z.-N.G., Y.Y. All authors approved the final version to be published.

Author information

Author notes

  1. Fu-Liang Zhang and Zhen-Ni Guo contributed equally to this work.

Authors and Affiliations

  1. Stroke Center, Department of Neurology, The First Hospital of Jilin University, Chang Chun, Jilin, 130021, China

    Fu-Liang Zhang, Hao-Yuan Liu & Yi Yang

  2. Neuroscience Center, Department of Neurology, The First Hospital of Jilin University, Chang Chun, Jilin, 130021, China

    Zhen-Ni Guo, Ying-Qi Xing & Yi Yang

  3. Division of Clinical Research, The First Hospital of Jilin University, Changchun, Jilin, 130021, China

    Yan-Hua Wu

Authors
  1. Fu-Liang Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhen-Ni Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ying-Qi Xing
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yan-Hua Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hao-Yuan Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yi Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yi Yang.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Electronic Supplementary Material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, FL., Guo, ZN., Xing, YQ. et al. Hypertension prevalence, awareness, treatment, and control in northeast China: a population-based cross-sectional survey. J Hum Hypertens 32, 54–65 (2018). https://doi.org/10.1038/s41371-017-0003-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41371-017-0003-4

This article is cited by

Search

Advanced search

Quick links